
|Articles|May 1, 2002
Supplements and Featured Publications
- Cost and Utilization Analysis for Rheumatoid Arthritis Treatments: An Update for Managed Care
- Volume 8
- Issue 7 Suppl
Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population
Advertisement
Articles in this issue
over 23 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Value-Based Care Interventions and Management of CKD Progression
5